Kay Schaller

Kay Schaller is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, located at Universitetsparken 2, 2100 Copenhagen Ø. Contactable via phone +4535334937 and email kay.schaller@sund.ku.dk, Schaller's work bridges pharmacological research and industrial biotechnology within the institution's drug design framework.

Research focuses on receptor pharmacology and enzyme engineering, specifically investigating GPR15 receptor interactions with peptide analogues and applying the Sabatier principle to industrial enzyme optimization. This dual-track approach integrates molecular pharmacology with biocatalysis, targeting therapeutic development and sustainable industrial processes through mechanistic studies of biological systems.

Recent publications demonstrate expertise in structure-activity relationship analysis for peptide-based drug candidates and strategic frameworks for enzyme engineering. The 2023 receptor study advances GPCR-targeted therapeutics, while the 2022 Sabatier principle review establishes methodologies for industrial biocatalyst development, reflecting consistent contributions to both academic pharmacology and applied biotechnology fields.